百济神州(06160)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

06160 百济神州

未开盘 04-24 16:08:16

87.000

+5.000

+6.10%

最高87.600	最低83.050	成交量195.88万
今开83.050	昨收82.000	日振幅5.55%
总市值1,183亿	流通市值1,183亿	总股本13.60亿
成交额1.68亿	换手率0.14%	流通股本13.60亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"06160","market":"HK","secType":"STK","nameCN":"百济神州","latestPrice":87,"timestamp":1713946096019,"preClose":82,"halted":0,"volume":1958781,"delay":0,"floatShares":1359524369,"shares":1359524369,"eps":-5.088347,"marketStatus":"未开盘","marketStatusCode":0,"change":5,"latestTime":"04-24 16:08:16","open":83.05,"high":87.6,"low":83.05,"amount":168351493,"amplitude":0.055488,"askPrice":87,"askSize":8700,"bidPrice":86.8,"bidSize":1900,"shortable":3,"etf":0,"ttmEps":-5.088346777351398,"exchange":"SEHK","tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1714008600000},"adr":0,"listingDate":1533657600000,"adjPreClose":82,"openAndCloseTimeList":[[1713922200000,1713931200000],[1713934800000,1713945600000]],"volumeRatio":1.3875545043895845,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD","astockBrief":{"symbol":"688235","market":"SH","secType":"STK","nameCN":"百济神州","latestPrice":124.42,"timestamp":1713942000000,"preClose":125.05,"halted":0,"volume":1691173,"delay":0,"premium":"-35.07"}},"requestUrl":"/m/hq/s/06160","defaultTab":"news","newsList":[{"id":"2429456166","title":"百济神州上涨3.23%，报143.48美元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2429456166","media":"金融界","top":-1,"share":"https://www.laohu8.com/m/news/2429456166?lang=zh_cn&edition=full","pubTime":"2024-04-24 21:30","pubTimestamp":1713965432,"startTime":"0","endTime":"0","summary":"4月24日，百济神州(BGNE)开盘上涨3.23%，截至21:30，报143.48美元/股，成交76.59万美元。财务数据显示，截至2023年12月31日，百济神州收入总额24.59亿美元，同比增长73.65%；归母净利润-8.82亿美元，同比增长56.0%。大事提醒：5月2日，百济神州将披露2024财年一季报。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://usstock.jrj.com.cn/2024/04/24213040392874.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2429170298","title":"百济神州现涨近4% 欧盟已授予替雷利珠单抗注射液上市许可","url":"https://stock-news.laohu8.com/highlight/detail?id=2429170298","media":"新浪港股","top":-1,"share":"https://www.laohu8.com/m/news/2429170298?lang=zh_cn&edition=full","pubTime":"2024-04-24 11:49","pubTimestamp":1713930540,"startTime":"0","endTime":"0","summary":"百济神州（06160）早盘持续升高，上涨3.90%，现报85.20港元，成交额5132.65万港元。\n　　4月23日，百济神州公告，公司近日获悉，欧盟委员会已授予百泽安®（替雷利珠单抗注射液）上市许可，批准其用于三项非小细胞肺癌（NSCLC）适应症的一线及二线治疗。\n\n股市回暖，抄底炒股先开户！智能定投、条件单、个股雷达……送给你>>\n\n\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"highlight_sina","url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2024-04-24/doc-inasxeca8657441.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}","selectors":".art_box, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action, .fl_popup, .weibo_info","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2024-04-24/doc-inasxeca8657441.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2429253177","title":"港股异动 | 百济神州(06160)涨近4% 替雷利珠单抗获欧盟委员会批准用于治疗非小细胞肺癌","url":"https://stock-news.laohu8.com/highlight/detail?id=2429253177","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2429253177?lang=zh_cn&edition=full","pubTime":"2024-04-24 11:31","pubTimestamp":1713929479,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，百济神州(06160)涨近4%，截至发稿，涨3.54%，报84.9港元，成交额4813.84万港元。消息面上，百济神州宣布欧盟委员会（EC）已批准替雷利珠单抗用于三项非小细胞肺癌（NSCLC）适应症的一线及二线治疗。被批准用于上述NSCLC适应症的替雷利珠单抗商品名为TIZVENI®。公司计划将NSCLC适应症与ESCC二线治疗适应症统一合并至商品名TEVIMBRA®下，TEVIMBRA®将于今年晚些时候在首批欧盟国家上市。目前，百济神州已启动超过17项替雷利珠单抗的潜在注册性研究，其中，11项3期随机对照研究和4项2期研究均获得积极数据。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1108261.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2429211341","title":"智通港股早知道 | 一季度国内动力电池装机量同比增长43% iPhone在华销量锐减19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2429211341","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2429211341?lang=zh_cn&edition=full","pubTime":"2024-04-24 07:32","pubTimestamp":1713915121,"startTime":"0","endTime":"0","summary":"GGII：第一季度国内动力电池装机量约84.3GWh 同比增长43%智通财经APP获悉，在新车上市、降价促销以及以旧换新政策刺激下，2024年第一季度国内新能源汽车延续快速增长势态。其中，第一季度新能源汽车销量前十企业合计装机约56.8GWh，占整个动力电池装机量的67.4%，宁德时代和比亚迪动力电池分别配套销量前十企业49%和37%的份额。2024年第一季度，特斯拉的汽车收入同比下降13%，至173.4亿美元。备案通知书将自2024年4月18日起12个月内有效。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1108158.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2429119833","title":"港股公告掘金 | 中国平安第一季度归母净利367.09亿元 经营保持稳健 核心业务恢复增长","url":"https://stock-news.laohu8.com/highlight/detail?id=2429119833","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2429119833?lang=zh_cn&edition=full","pubTime":"2024-04-23 22:53","pubTimestamp":1713883992,"startTime":"0","endTime":"0","summary":"【重大事项】出门问问(02438)每股定价3.8港元 公开发售获117.39倍认购亨鑫科技(01085)拟折让约17.24%配股 最高净筹约7260万港元弘海高新资源(00065)拟4000万元收购老挝泰山久久投资的全部股权太和控股(00718)拟5000万英镑出售Wide Flourish Investments Limited全部已发行股份复宏汉霖(02696)：HLX6018在健康受试者中开","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1108127.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2429195834","title":"百济神州(06160.HK)：替雷利珠单抗获欧盟委员会批准用于治疗非小细胞肺癌","url":"https://stock-news.laohu8.com/highlight/detail?id=2429195834","media":"格隆汇资讯","top":-1,"share":"https://www.laohu8.com/m/news/2429195834?lang=zh_cn&edition=full","pubTime":"2024-04-23 19:39","pubTimestamp":1713872393,"startTime":"0","endTime":"0","summary":"格隆汇4月23日丨百济神州于2024年4月23日宣布，欧盟委员会已批准替雷利珠单抗用于三项非小细胞肺癌适应症的一线及二线治疗。EGFR突变或ALK突变阳性的NSCLC患者在接受替雷利珠单抗治疗前应当已接受过靶向治疗。被批准用于上述NSCLC适应症的替雷利珠单抗商品名为TIZVENI。目前，百济神州已启动超过17项替雷利珠单抗的潜在注册性研究，其中，11项3期随机对照研究和4项2期研究均获得积极数据。迄今为止，替雷利珠单抗已惠及超过90万全球患者。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042319403787a5ffd5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042319403787a5ffd5&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2429164082","title":"百济神州(688235.SH)：欧盟委员会批准百泽安®用于3项非小细胞肺癌适应症的一线及二线治疗","url":"https://stock-news.laohu8.com/highlight/detail?id=2429164082","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2429164082?lang=zh_cn&edition=full","pubTime":"2024-04-23 18:18","pubTimestamp":1713867537,"startTime":"0","endTime":"0","summary":"EGFR突变或ALK突变阳性的NSCLC患者在接受替雷利珠单抗治疗前应当已接受过靶向治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1107680.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2429640971","title":"百济神州替雷利珠单抗获欧盟委员会批准用于治疗非小细胞肺癌","url":"https://stock-news.laohu8.com/highlight/detail?id=2429640971","media":"美通社","top":-1,"share":"https://www.laohu8.com/m/news/2429640971?lang=zh_cn&edition=full","pubTime":"2024-04-23 18:05","pubTimestamp":1713866700,"startTime":"0","endTime":"0","summary":"此次EC的决定标志着替雷利珠单抗在该地区获得第二项批准，在欧盟地区，替雷利珠单抗可用于治疗NSCLC和局部晚期或转移性食管鳞状细胞癌。EGFR突变或ALK突变阳性的NSCLC患者在接受替雷利珠单抗治疗前应当已接受过靶向治疗。迄今为止，替雷利珠单抗已惠及超过90万全球患者。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"https://wwwold.prnasia.com/story/archive/4392423_ZH92423_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2429515045","title":"百济神州04月23日遭主力抛售189万元 环比增加127.71%","url":"https://stock-news.laohu8.com/highlight/detail?id=2429515045","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2429515045?lang=zh_cn&edition=full","pubTime":"2024-04-23 16:15","pubTimestamp":1713860118,"startTime":"0","endTime":"0","summary":"04月23日, 百济神州股价涨2.95%，报收82.00元，成交金额1.36亿元，换手率0.13%，振幅3.89%，量比1.30。百济神州今日主力资金净流出189万元，上一交易日主力净流出83万元，今日环比增加127.71%。该股近5个交易日下跌0.12%，主力资金累计净流入1390万元，其中2个交易日为股价上涨时净流出；近20日主力资金累计净流入1919万元，其中净流入天数为12日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042316153187a53078&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042316153187a53078&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2429872531","title":"南向资金4月22日净买入百济神州25.34万股 连续3日增持","url":"https://stock-news.laohu8.com/highlight/detail?id=2429872531","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2429872531?lang=zh_cn&edition=full","pubTime":"2024-04-23 09:31","pubTimestamp":1713835874,"startTime":"0","endTime":"0","summary":"4月22日, 南向资金增持百济神州25.34万股，连续3日增持。截止当日收盘，港股通共持有百济神州5257.94万股，占流通股3.85%。百济神州近5个交易日下跌5.18%，港股通累计增持31.63万股；近20个交易日下跌22.37%，港股通累计增持216.90万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042309473187a38916&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042309473187a38916&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2429596865","title":"博时基金万琼旗下博时恒生医疗保健ETF一季报最新持仓，重仓百济神州","url":"https://stock-news.laohu8.com/highlight/detail?id=2429596865","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2429596865?lang=zh_cn&edition=full","pubTime":"2024-04-22 08:25","pubTimestamp":1713745511,"startTime":"0","endTime":"0","summary":"证券之星消息，4月22日博时基金旗下万琼管理的博时恒生医疗保健交易型开放式指数基金(QDII)公布一季报，近1年净值增长率-44.16%。与上一季度相比，该基金前十大重仓股新增阿里健康；其中百济神州持仓占比10.35%，为该基金第一大重仓股；药明康德等退出前十大重仓股；详细数据如下：以上内容由证券之星根据公开信息整理，由算法生成（网信算备310104345710301240019号），与本站立场无关，如数据存在问题请联系我们。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042200000912.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2428638481","title":"百济神州04月19日主力资金流入641万元 连续7日加仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2428638481","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2428638481?lang=zh_cn&edition=full","pubTime":"2024-04-19 16:15","pubTimestamp":1713514540,"startTime":"0","endTime":"0","summary":"04月19日, 百济神州股价跌2.78%，报收77.00元，成交金额1.39亿元，换手率0.15%，振幅4.73%，量比1.78。百济神州今日主力资金净流入641万元，连续7日净流入，上一交易日主力净流入608万元，今日环比增加5.43%。近一年数据显示，该股主力连续7日净流入后，次日上涨概率为60.00%，平均涨幅为1.85%。该股近5个交易日下跌10.39%，主力资金累计净流入2275万元；近20日主力资金累计净流入3480万元，其中净流入天数为14日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404191615598794aef3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404191615598794aef3&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2428520381","title":"百济神州获融资买入0.13亿元，近三日累计买入0.29亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2428520381","media":"金融界","top":-1,"share":"https://www.laohu8.com/m/news/2428520381?lang=zh_cn&edition=full","pubTime":"2024-04-19 08:21","pubTimestamp":1713486102,"startTime":"0","endTime":"0","summary":"4月18日，沪深两融数据显示，百济神州获融资买入额0.13亿元，居两市第601位，当日融资偿还额0.06亿元，净买入707.20万元。最近三个交易日，16日-18日，百济神州分别获融资买入0.06亿元、0.10亿元、0.13亿元。融券方面，当日融券卖出0.54万股，净买入0.59万股。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404190821478792723c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404190821478792723c&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2428597614","title":"真坑！基民喊话万家基金黄兴亮：你被菜市大妈吊打了","url":"https://stock-news.laohu8.com/highlight/detail?id=2428597614","media":"深蓝财经","top":-1,"share":"https://www.laohu8.com/m/news/2428597614?lang=zh_cn&edition=full","pubTime":"2024-04-18 18:52","pubTimestamp":1713437527,"startTime":"0","endTime":"0","summary":"■  传疯了！诺安基金前顶流蔡嵩松获刑？本人回应...■  民生银行踩雷地产，董事长年薪大降至373万，但仍是“年薪一哥”来源 ｜ 深蓝财经撰文 ｜ 王鑫随着前明星基金经理蔡嵩松受贿案的细节曝光，原来公募为游资接盘的传闻都是真的，这无疑给公募基金行业丢下了一颗重磅炸弹，基金经理们还值得信任吗？近两三年，“基...","market":"hk","thumbnail":"https://inews.gtimg.com/om_ls/OPmmoSTeuGWgoMEM2VuJdws8ZG3E-gEqA5zY-OcV1fLMEAA_294195/0","type":0,"news_type":0,"thumbnails":["https://inews.gtimg.com/om_ls/OPmmoSTeuGWgoMEM2VuJdws8ZG3E-gEqA5zY-OcV1fLMEAA_294195/0"],"rights":{"source":"tencent_tech","url":"https://new.qq.com/rain/a/20240418A08BUW00","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.title{#titleStyle#}a{#lv2TextColor#}.author, .pubtime{#sourceStyle#; display: inline-block;} .pubtime{margin-left: 3px;}strong{font-weight:500;#lv2TextColor#}","selectors":".main-wrapper","filters":".follow_top, .channel-entry, .collapseWrapper, .pic, .gap, .showDividingLine, .loader, .container, .ct-sumary, .nav, .landad, .hairline-top, .footer, .recommend-modules, .headroom-wrapper, .elevator","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://new.qq.com/rain/a/20240418A08BUW00","is_publish_highlight":false,"gpt_icon":0},{"id":"2428930323","title":"百济神州04月17日主力资金流入412万元 连续5日加仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2428930323","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2428930323?lang=zh_cn&edition=full","pubTime":"2024-04-17 16:16","pubTimestamp":1713341804,"startTime":"0","endTime":"0","summary":"04月17日, 百济神州股价跌1.28%，报收81.05元，成交金额9062万元，换手率0.09%，振幅3.41%，量比1.21。百济神州今日主力资金净流入412万元，连续5日净流入，上一交易日主力净流入414万元，今日环比减少0.48%。近一年数据显示，该股主力连续5日净流入后，次日上涨概率为50.00%，平均涨幅为4.58%。该股近5个交易日下跌12.88%，主力资金累计净流入1276万元；近20日主力资金累计净流入1772万元，其中净流入天数为13日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404171617118787fd40&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404171617118787fd40&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2428741365","title":"港股概念追踪 |北京支持创新医药高质量发展政策出台  机构看好国产创新药产业链崛起（附概念股）","url":"https://stock-news.laohu8.com/highlight/detail?id=2428741365","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2428741365?lang=zh_cn&edition=full","pubTime":"2024-04-17 14:10","pubTimestamp":1713334218,"startTime":"0","endTime":"0","summary":"北京市医疗保障局、北京市药品监督管理局等多部门发布北京市支持创新医药高质量发展若干措施。近日，北京、广州、珠海等多地政府先后发布了支持创新药高质量发展的利好政策，从多个产业链条环节发布相应支持政策，全方位促进创新药发展。康哲药业：创新药高选择性TYK2抑制剂CMS-D001及GnRH受体拮抗剂CMS-D002获药物临床试验批准通知书。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1103769.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2427139158","title":"【券商聚焦】招银国际料今年中国医药行业有望回归健康增长","url":"https://stock-news.laohu8.com/highlight/detail?id=2427139158","media":"金吾财讯","top":-1,"share":"https://www.laohu8.com/m/news/2427139158?lang=zh_cn&edition=full","pubTime":"2024-04-16 14:56","pubTimestamp":1713250565,"startTime":"0","endTime":"0","summary":"金吾财讯 | 招银国际表示，年初至今，MSCI中国医疗指数下跌22.7%，跑输MSCI中国指数23.3%。展望2024年，随着行业监管常态化进行，新冠基数影响逐渐消退，中国医药行业有望回归健康增长。另外，行业监管仍呈现持续高压态势，预计院内刚需将在下半年出现需求复苏。该行认为，行业严格监管或将常态化，然而，诊疗秩序逐步正常，院内产品和服务的需求仍将保持健康。考虑到基数原因，该行预期行业或将于今年下半年加速增长。","market":"other","thumbnail":"https://static.szfiu.com/news/20210810/YjQxYWY4NjkyMTU2YjM4ZTVhNGFhMzYzNjE2NzgxMDU=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210810/YjQxYWY4NjkyMTU2YjM4ZTVhNGFhMzYzNjE2NzgxMDU=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"1935150","is_publish_highlight":false,"gpt_icon":0},{"id":"2427850430","title":"南向资金4月15日净买入百济神州23.99万股 连续3日增持","url":"https://stock-news.laohu8.com/highlight/detail?id=2427850430","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2427850430?lang=zh_cn&edition=full","pubTime":"2024-04-16 09:31","pubTimestamp":1713231090,"startTime":"0","endTime":"0","summary":"4月15日, 南向资金增持百济神州23.99万股，连续3日增持。截止当日收盘，港股通共持有百济神州5226.30万股，占流通股3.84%。百济神州近5个交易日下跌6.72%，港股通累计增持27.33万股；近20个交易日下跌19.00%，港股通累计增持364.33万股。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404160943538781e7cf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404160943538781e7cf&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2427850259","title":"北向资金4月15日净买入百济神州-U1.57万股 连续3日增持","url":"https://stock-news.laohu8.com/highlight/detail?id=2427850259","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2427850259?lang=zh_cn&edition=full","pubTime":"2024-04-16 09:30","pubTimestamp":1713231036,"startTime":"0","endTime":"0","summary":"4月15日, 北向资金增持百济神州-U1.57万股，连续3日增持。截止当日收盘，沪股通共持有百济神州-U531.20万股，占流通股4.61%。沪股通增持金额前五个股分别为贵州茅台、中国建筑、山西汾酒、兴业银行、招商银行。百济神州-U近5个交易日下跌2.38%，沪股通累计增持24.74万股；近20个交易日下跌10.75%，沪股通累计增持128.51万股。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404160935088781df2d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404160935088781df2d&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2427853720","title":"百济神州(06160)：建议授予董事受限制股份单位及业绩股份单位","url":"https://stock-news.laohu8.com/highlight/detail?id=2427853720","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2427853720?lang=zh_cn&edition=full","pubTime":"2024-04-16 07:37","pubTimestamp":1713224265,"startTime":"0","endTime":"0","summary":"智通财经APP讯，百济神州 发布公告，董事会已议决根据2016年计划建议授予受限制股份单位及业绩股份单位如下，但须获接纳及于股东周年大会上获独立股东批准方可作实：授予欧雷强先生于授予日期公平值为600万美元的受限制股份单位;授予欧雷强先生于授予日期公平值为600万美元的业绩股份单位;授予王晓东博士于授予日期公平值为133.33万美元的受限制股份单位;及授予各独立非执行董事于授予日期公平值为20万美元的受限制股份单位。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1103026.html","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.beigene.com","stockEarnings":[{"period":"1week","weight":0.0734},{"period":"1month","weight":-0.0497},{"period":"3month","weight":-0.0998},{"period":"6month","weight":-0.1722},{"period":"1year","weight":-0.4227},{"period":"ytd","weight":-0.2098}],"compareEarnings":[{"period":"1week","weight":0.0584},{"period":"1month","weight":0.0442},{"period":"3month","weight":0.061},{"period":"6month","weight":-0.0113},{"period":"1year","weight":-0.1232},{"period":"ytd","weight":0.009}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"百济神州有限公司是一家主要从事生物制药业务的公司。该公司主要从事用于治疗癌症的创新分子靶向及免疫肿瘤药物的研发，生产和销售业务。该公司的主要产品包括Zanubrutinib（BGB-3111），Tislelizumab（BGB-A317）和Pamiparib（BGB-290）等。","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":-0.03281},{"month":2,"riseRate":0.5,"avgChangeRate":0.020001},{"month":3,"riseRate":0.166667,"avgChangeRate":-0.060772},{"month":4,"riseRate":0.5,"avgChangeRate":0.038664},{"month":5,"riseRate":0.4,"avgChangeRate":-0.051509},{"month":6,"riseRate":0.6,"avgChangeRate":0.018734},{"month":7,"riseRate":0.8,"avgChangeRate":0.062642},{"month":8,"riseRate":0.8,"avgChangeRate":0.040871},{"month":9,"riseRate":0.333333,"avgChangeRate":-0.025087},{"month":10,"riseRate":0.666667,"avgChangeRate":0.006083},{"month":11,"riseRate":0.5,"avgChangeRate":0.130955},{"month":12,"riseRate":0.166667,"avgChangeRate":-0.054912}],"exchange":"SEHK","name":"百济神州","nameEN":"BEIGENE"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"百济神州(06160)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供百济神州(06160)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"百济神州,06160,百济神州股票,百济神州股票老虎,百济神州股票老虎国际,百济神州行情,百济神州股票行情,百济神州股价,百济神州股市,百济神州股票价格,百济神州股票交易,百济神州股票购买,百济神州股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"百济神州(06160)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供百济神州(06160)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}